MicuRx Pharmaceuticals Inks $9.6 Million Pact With Shanghai Zhangjiang Biomedical Industry Venture Capital
10/24/2012 7:33:45 AM
More...
|
MicuRx Pharmaceuticals Announces Issuance of U.S. Patent for Its Next-Generation Antibacterial Agent
5/23/2012 10:40:18 AM
More...
|
MicuRx Pharmaceuticals Completes Phase 1 Trial For MRX-I, A Next-Generation Antibiotic
4/23/2012 9:52:19 AM
More...
|
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I - MRX-I Targets Multi-Drug Resistant Gram Positive Infections
3/15/2010 10:30:30 AM
More...
|
MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
8/19/2008 10:17:56 AM
More...
|
MicuRx Pharmaceuticals Completes $10 Million Series A Financing to Fund Discovery and Development of Next-Generation Antibiotics
6/25/2007 9:50:59 AM
More...
|